Deyaa Adib - 22 Apr 2024 Form 3 Insider Report for FIBROGEN INC (FGEN)

Role: Chief Medical Officer
Signature: /s/ Michael Hom, Attorney-in-Fact
Issuer symbol: FGEN
Transactions as of: 22 Apr 2024
Transactions value $: $0
Form type: 3
Filing time: 24 Apr 2024, 16:15:00
Next filing: 13 Jun 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	FGEN	Common Stock						60K	22 Apr 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	FGEN	Stock Option (Right to Buy)							22 Apr 2024	Common Stock	300K	$1.71	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units (RSUs). Twenty-five percent of the RSUs will vest on March 11, 2025, and the remainder of the RSUs will vest in equal amounts quarterly thereafter for the following three years.
F2	Twenty-five percent of the shares subject to the option will vest on March 11, 2025, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years.